Ben-Gurion University Researchers to Develop Novel Biological Treatment for Inflammatory Bowel Diseases prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Researchers at Ben-Gurion University of the Negev (BGU) are developing a novel therapeutic strategy for treating Inflammatory Bowel Diseases.
Share this article
Share this article
BEER-SHEVA, Israel, April 8, 2021 /PRNewswire/ Researchers at Ben-Gurion University of the Negev (BGU) have identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, led by Ms. Orit Malka, a PhD student in the laboratory of Prof. Raz Jelinek, the Vice President and Dean for Research & Development at BGU, was published in
Microbiome, a leading peer-reviewed publication.
Prof. Raz Jelinek and Ms. Orit Malka with their unique probiotic yogurt at Ben-Gurion University laboratory (Credit: Dani Machlis) (PRNewsfoto/BGN Technologies)
Share this article
Share this article
BEER-SHEVA, Israel, April 8, 2021 /PRNewswire/ Researchers at Ben-Gurion University of the Negev (BGU) have identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, led by Ms. Orit Malka, a PhD student in the laboratory of Prof. Raz Jelinek, the Vice President and Dean for Research & Development at BGU, was published in
Microbiome, a leading peer-reviewed publication.
Prof. Raz Jelinek and Ms. Orit Malka with their unique probiotic yogurt at Ben-Gurion University laboratory (Credit: Dani Machlis) (PRNewsfoto/BGN Technologies)